Sign In
Buy AMGN
$345.60
+7.38 (+2.18%)
At Close: Jun 04, 2026
5 Biotech Stocks Set to Outpace Q3 Earnings Estimates
12:47pm, Wednesday, 18'th Oct 2023
Let us look at some biotech stocks, AMGN, BIIB, GSK, PRTA and VRTX, which are poised to beat on third-quarter earnings.
Dividend Income Update September 2023
08:30pm, Tuesday, 17'th Oct 2023
With the start of the final quarter of 2023, it's time to take a look back at my previous month of dividend income. Getting close to that $2,000 milestone in a month sure looks amazing. I know, those
PBYI vs. AMGN: Which Stock Is the Better Value Option?
12:46pm, Tuesday, 17'th Oct 2023
Investors looking for stocks in the Medical - Biomedical and Genetics sector might want to consider either Puma Biotech (PBYI) or Amgen (AMGN). But which of these two stocks is more attractive to valu
Investors Heavily Search Amgen Inc. (AMGN): Here is What You Need to Know
10:32am, Tuesday, 17'th Oct 2023
Amgen (AMGN) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Will Amgen (AMGN) Beat Estimates Again in Its Next Earnings Report?
01:32pm, Monday, 16'th Oct 2023
Amgen (AMGN) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Which Is A Better Pick – Abbott Stock Or Amgen?
08:00am, Monday, 16'th Oct 2023
There is more to the comparison, and in the sections below, we discuss why we believe ABT will offer better returns than AMGN in the next three years.
TScan Therapeutics: That Recent Amgen Deal Is The Only Point Of Interest
03:32am, Saturday, 14'th Oct 2023
TScan Therapeutics is developing TCR T-cell therapies for cancer using a transposon-based T cell engineering method. The company aims to target a broader patient population by addressing a wide range
Amgen: Horizon's Pipeline May Be Too Expensive
02:00pm, Friday, 13'th Oct 2023
We believe that AMGN has overpaid for HZNP's pipeline, since most of its upside potential is attributed to price increases instead of the expanding TAM. The growing debt may also pose headwinds to its
Is This Dividend Stock a Screaming Buy After Its Latest Acquisition?
08:30am, Friday, 13'th Oct 2023
Amgen finally closed its acquisition of Horizon Therapeutics despite a regulatory hiccup. Horizon has a relatively impressive portfolio although, like Amgen, it has growth issues.
Is Amgen Stock a Buy Now?
05:25am, Friday, 13'th Oct 2023
The company's growth rate has been underwhelming in recent years. Amgen relied on acquisitions in recent years to enhance its growth opportunities.
(AMGN) Rises As Market Takes a Dip: Key Facts
07:32pm, Thursday, 12'th Oct 2023
In the closing of the recent trading day, Amgen (AMGN) stood at $285.04, denoting a +0.51% change from the preceding trading day.
Amgen's (AMGN) Stock Rallies Almost 5% on Broker Upgrade
01:32pm, Thursday, 12'th Oct 2023
A Leerink Partner analyst expects accelerating pipeline news flow for Amgen (AMGN).
Prescriptions for Portfolio Health: 3 Resilient Healthcare Stocks
08:01am, Thursday, 12'th Oct 2023
Over the last several months, many sectors, industries, and the overall market have come under pressure and experienced significant outflows and waves of selling.
Top Stocks October 11, 2023: Plug Power, ChargePoint, Amgen
06:20pm, Wednesday, 11'th Oct 2023
Plug Power (PLUG) shares close Wednesday higher after raising its forward revenue outlook through 2027. EV infrastructure company ChargePoint's (CHPT) stock tumbles while raising $232 million in its p
Amgen's cancer-drug pipeline looks promising despite FDA setback, analysts say
08:47am, Wednesday, 11'th Oct 2023
Amgen Inc.'s AMGN, -0.11% pipeline of cancer, obesity and cardiovascular drugs is poised to deliver good news for the stock, analysts say, despite the company's recent setback with cancer drug Lumakra
